Regeneron Pharmaceuticals Inc.

In News

Zurcher Kantonalbank Zurich Cantonalbank Sells 17,601 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

MarketBeat - Apr 21, 2026

Regeneron’s Lunsekimig Data Expand Immunology Story Beyond Dupixent Dependency - simplywall.st

simplywall.st - Apr 21, 2026

Regeneron and Telix Announce Strategic Radiopharma Collaboration | Regeneron Pharmaceuticals Inc. - Regeneron

Regeneron - Apr 13, 2026

Regeneron Pharmaceuticals (REGN) Announces Collaboration With Telix Pharmaceuticals Limited - Yahoo Finance

Yahoo Finance - Apr 20, 2026

A shot every 12 weeks controlled myasthenia gravis in Phase 3 - Stock Titan

Stock Titan - Apr 21, 2026

Regeneron (REGN) Presents NIMBLE Trial Findings for Cemdisiran i - GuruFocus

GuruFocus - Apr 21, 2026

Regeneron Pharmaceuticals Announces Positive Phase 3 NIMBLE Trial Results For Cemdisiran In gMG - TradingView

TradingView - Apr 21, 2026

Regeneron Pharmaceuticals, Inc. $REGN Stake Raised by Merit Financial Group LLC - MarketBeat

MarketBeat - Apr 21, 2026

Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions - Regeneron

Regeneron - Apr 02, 2026

What Regeneron Pharmaceuticals (REGN)'s Expanded EU Pediatric Approval for Dupixent Means For Shareholders - simplywall.st

simplywall.st - Apr 20, 2026

Private Wealth Partners LLC Purchases Shares of 2,270 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

MarketBeat - Apr 21, 2026

Belpointe Asset Management LLC Invests $1.74 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

MarketBeat - Apr 21, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment